Bioxcel Therapeutics Submits Pre-Supplemental New Drug Application Meeting Package In Support Of Potential Label Expansion For Igalmi
July 21 (Reuters) - BioXcel Therapeutics Inc BTAI.O:
BIOXCEL THERAPEUTICS SUBMITS PRE-SUPPLEMENTAL NEW DRUG APPLICATION MEETING PACKAGE IN SUPPORT OF POTENTIAL LABEL EXPANSION FOR IGALMI®
BIOXCEL THERAPEUTICS INC - PRE-SNDA MEETING WITH FDA SCHEDULED FOR AUGUST 20, 2025
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.